MiniMed Group (B8S) Stock Overview
Operates as a medical technology company that develops, manufactures, and markets medical equipment for the management of diabetes. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 4/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
B8S Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
MiniMed Group, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$12.85 |
| 52 Week High | US$17.09 |
| 52 Week Low | US$9.04 |
| Beta | 0 |
| 1 Month Change | 36.70% |
| 3 Month Change | -10.14% |
| 1 Year Change | n/a |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -20.35% |
Recent News & Updates
Recent updates
Shareholder Returns
| B8S | DE Medical Equipment | DE Market | |
|---|---|---|---|
| 7D | 4.0% | 3.4% | -2.6% |
| 1Y | n/a | -27.3% | -1.4% |
Return vs Industry: Insufficient data to determine how B8S performed against the German Medical Equipment industry.
Return vs Market: Insufficient data to determine how B8S performed against the German Market.
Price Volatility
| B8S volatility | |
|---|---|
| B8S Average Weekly Movement | 9.9% |
| Medical Equipment Industry Average Movement | 6.2% |
| Market Average Movement | 5.9% |
| 10% most volatile stocks in DE Market | 13.2% |
| 10% least volatile stocks in DE Market | 2.7% |
Stable Share Price: B8S's share price has been volatile over the past 3 months compared to the German market.
Volatility Over Time: Insufficient data to determine B8S's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1983 | 8,000 | Que Dallara | www.minimed.com |
MiniMed Group, Inc. operates as a medical technology company that develops, manufactures, and markets medical equipment for the management of diabetes. The company offers technologies including insulin delivery devices, including insulin pumps and pens, continuous glucose monitors, other consumables, supplies, and related software and services. It serves people with diabetes who require insulin therapy, which represents all people with T1D and a subset of those with T2D.
MiniMed Group, Inc. Fundamentals Summary
| B8S fundamental statistics | |
|---|---|
| Market cap | €3.68b |
| Earnings (TTM) | -€286.75m |
| Revenue (TTM) | €2.69b |
Is B8S overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| B8S income statement (TTM) | |
|---|---|
| Revenue | US$3.10b |
| Cost of Revenue | US$1.42b |
| Gross Profit | US$1.68b |
| Other Expenses | US$2.01b |
| Earnings | -US$331.00m |
Last Reported Earnings
Apr 24, 2026
Next Earnings Date
n/a
| Earnings per share (EPS) | -1.18 |
| Gross Margin | 54.16% |
| Net Profit Margin | -10.67% |
| Debt/Equity Ratio | 1.8% |
How did B8S perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/06/10 17:01 |
| End of Day Share Price | 2026/06/10 00:00 |
| Earnings | 2026/04/24 |
| Annual Earnings | 2026/04/24 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
MiniMed Group, Inc. is covered by 15 analysts. 12 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Matthew Miksic | Barclays |
| Bruce Jackson | Benchmark Company |
| Travis Steed | BofA Global Research |